
Professor Thomas Powles discusses the role of circulating tumor DNA assays in managing urothelial bladder cancer.
Professor Thomas Powles from Barts Cancer Institute in London, United Kingdom, discusses recent developments with circulating tumor DNA assays in the management of urothelial bladder cancer. CME information and select publications
Host: Dr. Neil Love
Guest: Professor Thomas Powles
Organizations: Barts Cancer Institute
Places: London, United Kingdom
Explore listener stats, chart rankings, contacts and more on the Prostate Cancer Update podcast page.